The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Expired CME Article
Low Bone Mineral Density in Premenopausal Women
Abstract
With the proliferation of bone densitometers, an increasing number of premenopausal women are having their bone density tested. Approximately 15% of premenopausal women have bone mineral density that is more than 1 standard deviation less than the young-adult mean, and approximately 0.6% are more than 2.5 standard deviation below young-adult mean bone density. Most pre-menopausal women with low bone density have low peak bone mass, stable bone density, and low short-term absolute risk of fracture. The management of these patients involves nonpharmacologic lifestyle measures and reassurances that fracture risk is low. A minority of premenopausal women with low bone density have increased short-term absolute fracture risk with contributing diseases, conditions, or medications that should be identified and treated. Premenopausal women with fractures are at increased risk for fractures later in life. Methods for evaluating these patients and selecting those who require additional care are reviewed.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO Study Group. World Health Organ Tech Rep Ser1994;843:1–129.
2. National Osteoporosis Foundation. Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC, National Osteoporosis Foundation, 1998.
3. Hodgson SF, Watts NB, Bilezikian JP, et al; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract 2001;7:293–312.
4. Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry: Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000;11:192–202.
5. Looker AC, Wahner HW, Dunn WL, et al. Proximal femur bone mineral levels of US adults.Osteoporos Int 1995;5:389–409.
6. Melton LJ III, Atkinson EJ, O’Connor MK, et al. Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 2000;15:24–31.
7. Bainbridge KE, Sowers MF, Crutchfield M, et al. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002;156:410–417.
8. Slemenda C, Longcope C, Peacock M, et al. Sex steroids, bone mass, and bone loss: A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996;97:14–21.
9. Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for diagnosis and management of osteoporosis: The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1997;7:390–406.
10. Hamdy RC, Petak SM, Lenchik L; International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis?J Clin Densitom 2002;5(Suppl):S11–S18.
11. Miller PD, Njeh CF, Jankowski LG, et al; International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis?J Clin Densitom 2002;5(Suppl):S39–S45.
12. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–795.
13. Melton LJ III, Chrischilles EA, Cooper C, et al. Perspective: How many women have osteoporosis?J Bone Miner Res 1992;7:1005–1010.
14. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254–1259.
15. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81:1804–1809.
16. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001;12:989–995.
17. Goulding A, Cannan R, Williams SM, et al. Bone mineral density in girls with forearm fractures. J Bone Miner Res 1998;13:143–148.
18. Goulding A, Jones IE, Taylor RW, et al. More broken bones: A 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011–2018.
19. Goulding A, Gold E, Walker R, et al. Women with past history of bone fracture have low spinal bone density before menopause. N Z Med J 1997;110:232–233.
20. Tuppurainen M, Kroger H, Honkanen R, et al. Risks of perimenopausal fractures: A prospective population-based study. Acta Obstet Gynecol Scand 1995;74:624–628.
21. Fiorano-Charlier C, Ostertag A, Aquino JP, et al. Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures. Bone 2002;31:102–106.
22. Hosmer WD, Genant HK, Browner WS. Fractures before menopause: A red flag for physicians.Osteoporos Int 2002;13:337–341.
23. Lauder TD, Dixit S, Pezzin LE, et al. The relation between stress fractures and bone mineral density: Evidence from active-duty Army women. Arch Phys Med Rehabil 2000;81:73–79.
24. Dent CE. Keynote address: Problems in metabolic bone disease, in Proceedings of the International Symposium on Clinical Aspects of Metabolic Bone Disease. 1973, 1–7.
25. Kanis JA. Osteoporosis. Oxford, UK, Blackwell Science. 1994.
26. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults: A twin study. J Clin Invest 1987;80:706–710.
27. Hawker GA, Jamal SA, Ridout R, et al. A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int 2002;13:400–406.
28. Peris P, Guanabens N, Alvarez N, et al. Clinical characteristics and aetiological factors of premenopausal osteoporosis. Bone 2001;28(5 Suppl 1):S185 (abstract).
29. Zipfel S, Seibel MJ, Löwe B, et al. Osteoporosis in eating disorders: A follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 2001;86:5227–5233.
30. Lucas AR, Melton LJ III, Crowson CS, et al. Long-term fracture risk among women with anorexia nervosa: A population-based cohort study. Mayo Clin Proc 1999;74:972–977.
31. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med 2003;163:286–292.
32. Ott SM, Scholes D, LaCroix AZ, et al. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 2001;86:179–185.
33. Berenson AB, Radecki CM, Grady JJ, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001;98:576–582.
34. Scholes D, LaCroix AZ, Ott SM, et al. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 1999;93:233–238.
35. Cundy T, Cornish J, Roberts H, et al. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 1998;92:569–573.
36. Scholes D, LaCroix AZ, Ichikawa LE, et al. A prospective evaluation of the effects on bone of discontinuing depot medroxyprogesterone acetate contraception. J Bone Miner Res 1999;14(Suppl 1):S384 (abstract).
37. Powles TJ, Hickish T, Kanis JA, et al. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol1996;14:78–84.
38. Uemura T, Mohri J, Osada H, et al. Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis. Fertil Steril 1994;62:246–250.
39. Agarwal SK. Impact of six months of GnRH agonist therapy for endometriosis: Is there an age-related effect on bone mineral density?J Reprod Med 2002;47:530–534.
40. Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348–1353.
41. Liporace J, D’Abreu A. Epilepsy and women’s health: Family planning, bone health, menopause, and menstrual-related seizures. Mayo Clin Proc 2003;78:497–506.
42. Mathias S, Nayak US, Isaacs B. Balance in elderly patients: The “get-up and go” test. Arch Phys Med Rehabil 1986;67:387–389.
43. Chapurlat RD, Gamero P, Sornay-Rendu E, et al. Longitudinal study of bone loss in pre- and perimenopausal women: Evidence for bone loss in perimenopausal women. Osteoporos Int2000;11:493–498.
44. Recker R, Lappe J, Davies K, et al. Characterization of perimenopausal bone loss: A prospective study. J Bone Miner Res 2000;15:1965–1973.
45. Bastian LA, Smith CM, Nanda K. Is this woman perimenopausal?JAMA 2003;289:895–902.
46. Johnston CC Jr, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992;327:82–87.
47. Zamora SA, Rizzoli R, Belli DC, et al. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 1999;84:4541–4544.
48. Petit MA, McKay HA, MacKelvie KJ, et al. A randomized school-based jumping intervention confers site and maturity-specific benefits on bone structural properties in girls: A hip structural analysis study.J Bone Miner Res 2002;17:363–372.
49. The effect of exercise training programs on bone mass: A meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999;9:1–12.
50. Sategna-Guidetti C, Grosso SB, Grosso S, et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients.Aliment Pharmacol Ther 2000;14(1):35–43.
51. Rauch F, Plotkin H, Zeitlin L, et al. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate therapy. J Bone Miner Res 2003;18:610–614.
52. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001;44:1496–1503.
53. Shargil AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: A three-year prospective study. Int J Fertil 1985;30:15, 18–28.
54. Gambacciani M, Ciaponi M, Cappagli B, et al. Longitudinal evaluation of perimenopausal femoral bone loss: Effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.Osteoporos Int 2000;11:544–548.
55. Pasco JA, Kotowicz MA, Henry MJ, et al. Oral contraceptives and bone mineral density: A population-based study. Am J Obstet Gynecol 2000;182:265–269.
56. Prior JC, Kirkland SA, Joseph L, et al. Oral contraceptive use and bone mineral density in premenopausal women: Cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ 2001;165:1023–1029.
57. Michaëlsson K, Baron JA, Farahmand BY, et al. Oral-contraceptive use and risk of hip fracture: A case-control study. Lancet 1999;353:1481–1484.
58. Cooper C, Hannaford P, Croft P, et al. Oral contraceptive pill use and fractures in women: A prospective study. Bone 1993;14:41–45.
59. Mitwally MF, Gotlieb L, Casper RF. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 2002;9:236–241.
60. Golden NH, Lanzkowsky L, Schebendach J, et al. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002;15:135–143.
61. Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: A method for setting intervention thresholds. Osteoporos Int 2001;12:417–427.
